Hill Rom Holdings (HRC)
Common Stock
HRC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. HRC has a bad profitability rating. Also its financial health evaluation is rather negative. HRC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
HRC had positive earnings in the past year.
Each year in the past 5 years HRC has been profitable.
In the past 5 years HRC always reported a positive cash flow from operatings.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.97% | ||
| ROE | 13.22% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.4% | ||
| PM (TTM) | 8.23% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, HRC has less shares outstanding
HRC has a worse debt/assets ratio than last year.
2.2 Solvency
HRC has an Altman-Z score of 3.60. This indicates that HRC is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.97 indicates that HRC is somewhat dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.6 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 1.38 indicates that HRC should not have too much problems paying its short term obligations.
A Quick Ratio of 1.05 indicates that HRC should not have too much problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.10% over the past year.
The Earnings Per Share has been growing by 13.30% on average over the past years. This is quite good.
The Revenue has been growing slightly by 4.78% in the past year.
Measured over the past years, HRC shows a small growth in Revenue. The Revenue has been growing by 2.60% on average per year.
EPS 1Y (TTM)14.1%
EPS 3Y9.93%
EPS 5Y13.3%
EPS growth Q2Q42.74%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y1.96%
Revenue growth 5Y2.6%
Revenue growth Q2Q13.13%
3.2 Future
Based on estimates for the next years, HRC will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.11% on average per year.
HRC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.87% yearly.
EPS Next Y3.85%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
EPS Next 5Y10.11%
Revenue Next Year3.75%
Revenue Next 2Y4.37%
Revenue Next 3Y5.68%
Revenue Next 5Y5.87%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.72 indicates a rather expensive valuation of HRC.
Compared to an average S&P500 Price/Earnings ratio of 24.84, HRC is valued at the same level.
A Price/Forward Earnings ratio of 23.80 indicates a rather expensive valuation of HRC.
The average S&P500 Price/Forward Earnings ratio is at 21.35. HRC is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.72 | ||
| Fwd PE | 23.8 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.16 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HRC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.41
PEG (5Y)1.86
EPS Next 2Y7.49%
EPS Next 3Y9.22%
5. Dividend
5.1 Amount
With a yearly dividend of 0.62%, HRC is not a good candidate for dividend investing.
With a Dividend Yield of 0.62, HRC pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
5.2 History
On average, the dividend of HRC grows each year by 6.42%, which is quite nice.
HRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
24.95% of the earnings are spent on dividend by HRC. This is a low number and sustainable payout ratio.
The dividend of HRC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.95%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
Hill Rom Holdings
NYSE:HRC (12/10/2021, 7:15:43 PM)
After market: 155.96 0 (0%)155.96
+0.05 (+0.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.42B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.72 | ||
| Fwd PE | 23.8 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)6.41
PEG (5Y)1.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.97% | ||
| ROE | 13.22% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 17.4% | ||
| PM (TTM) | 8.23% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)14.1%
EPS 3Y9.93%
EPS 5Y
EPS growth Q2Q
EPS Next Y3.85%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.78%
Revenue growth 3Y1.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y